Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1D | P25100 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 12/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 4/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 4/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.33 |
| ▸ | APLNR | P35414 | 1/20 | 0.33 |
| ▸ | CLK1 | P49759 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.31 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8950122 | 0.81 | TDP1 (0.42) | ADRA1DADRA1ADGAT1PIK3CAPIK3CB | |
| SCHEMBL8950449 | 0.79 | PIK3CD (0.48) | PIK3CAPIK3CBPIK3CGPIK3CDCYP11B2 | |
| SCHEMBL9007474 | 0.77 | KDM4E (0.34) | ADRA1DADRA1ACYP11B2 | |
| SCHEMBL8950312 | 0.75 | PIK3CA (0.43) | ADRA1DADRA1ADGAT1PIK3CAPIK3CB | |
| SCHEMBL24185681 | 0.72 | DGAT1 (0.41) | ADRA1DADRA1ADGAT1PIK3CAPIK3CB | |
| SCHEMBL30058163 | 0.70 | ALDH1A1 (0.47) | DGAT1PIK3CA | |
| SCHEMBL8950114 | 0.70 | ADRA1D (0.36) | ADRA1DADRA1ADGAT1PIK3CAPIK3CB | |
| SCHEMBL8950388 | 0.69 | PIK3CA (0.41) | ADRA1DADRA1APIK3CAPIK3CBPIK3CG | |
| SCHEMBL8950089 | 0.69 | PIK3CA (0.41) | ADRA1DADRA1ADGAT1PIK3CAPIK3CB | |
| SCHEMBL8950322 | 0.69 | DGAT1 (0.41) | ADRA1DADRA1ADGAT1PIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8188085-B2 | Antifungal agents | MERCK SHARP & DOHME CORP. (US) | 2012-05-29 | — | — | US | disclosed |
| US-20100113439-A1 | Antifungal agents | MERCK & CO., INC. (US) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113439-A1 | Antifungal agents | GMDS, GBA3, UGGT1 | ADRA1D 2746/4885ADRA1A 3372/4885DGAT1 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.